Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy EDITORIAL COMMENT

Wallis Christopher J. D.

首页> 外文期刊>The Journal of Urology >Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy EDITORIAL COMMENT

【24h】

Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy EDITORIAL COMMENT

机译：验证Gemcap作为基于DNA的生物标志物，以预测自由基前列腺切除术后前列腺癌复发

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2018年第3期|共1页
作者
Wallis Christopher J. D.;
展开▼
作者单位

Univ Toronto Toronto ON Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy EDITORIAL COMMENT [J] . Wallis Christopher J. D. The Journal of Urology . 2018,第3期

机译：验证Gemcap作为基于DNA的生物标志物，以预测自由基前列腺切除术后前列腺癌复发
2. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy [J] . Nguyen Hao G., Welty Christopher, Lindquist Karla, The Journal of Urology . 2018,第3期

机译：验证Gemcap作为基于DNA的生物标志物，以预测自由基前列腺切除后的前列腺癌复发
3. Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy [J] . Nguyen Hao G., Welty Christopher, Lindquist Karla, The Journal of Urology . 2018,第3期

机译：验证Gemcap作为基于DNA的生物标志物，以预测自由基前列腺切除后的前列腺癌复发
4. HIFU Therapy for Local Recurrence of Prostate Cancer after External Beam Radiotherapy and Radical Prostatectomy - 5,5 Years Experience [C] . V.A.Solovov, M.O.Vozdvizhenskiy, Y.S.Matysh International Symposium on Therapeutic Ultrasound (2002) . 2017

机译：HIFU治疗外梁放射治疗后前列腺癌的局部复发和激进前列腺切除术 - 5.5年经验
5. Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy [D] . KASHIHARA, Tairo 2019

机译：前列腺癌根治术后前列腺癌生化复发的挽救性外照射治疗中手术切缘阳性部位的重要性
6. Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer Patients Following Radical Prostatectomy [O] . Dimo Dietrich, Oliver Hasinger, Lionel L. Bañez, 2013

机译：PITX2 DNA甲基化实时PCR检测试剂盒的开发及临床验证以预测前列腺癌根治术后前列腺癌患者的前列腺特异性抗原复发。
7. Editorial Comment to Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databas [O] . Richard Viney 2010

机译：编辑评论对术后前列腺特异性抗原Nadir提高了预测自由基前列腺切除术后生物化学复发的准确性：来自共享平等接入区域癌症医院（搜索）和公爵前列腺中心数据库的结果
8. Validation of Biomarkers Predictive of Recurrence Following Prostatectomy. [R] . Moreno, C. S. 2012

机译：生物标志物的验证预测前列腺切除术后的复发。

Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy EDITORIAL COMMENT

著录项

相似文献

相关主题

期刊订阅